22 Jun 2020 14:15
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Publication of Shareholder Circular
Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and COVID-19 testing, confirms that the Circular to Shareholders in respect of the Fundraising, announced on 19 June 2020, is now available on the Company's website here:
http://www.omegadiagnostics.com/Investor-Relations/Corporate-Information
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive | www.omegadiagnostics.com |
Kieron Harbinson, Group Finance Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/Hannah Boros (Corporate Finance) | |
Camille Gochez (ECM) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
ODX.L (ODX)